We are live on
!
Find out more
Jasper Ridge Partners Portfolio holdings
AUM
$4.69B
Turnover
13.92%
1-Year Est. Return
31.34%
This Fund
S&P 500
This Quarter
Est. Return
-11.81%
1 Year Est. Return
+31.34%
3 Year Est. Return
+84.21%
5 Year Est. Return
+70.25%
10 Year Est. Return
+324.79%
AUM
$1.63B
AUM Growth
-$193M
(-11%)
Cap. Flow
+$36.5M
Cap. Flow
% of AUM
2.23%
Top 10 Holdings %
Top 10 Hldgs %
90.69%
Holding
77
New
4
Increased
9
Reduced
8
Closed
5
Avg Time Held
2.6
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$126M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$122M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$33M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$8.75M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$7.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$108M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$74.2M |
| 3 |
Nike
NKE
|
+$55.1M |
| 4 |
R1 RCM Inc. Common Stock
RCM
|
+$18.2M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.74% |
| 2 | Communication Services | 8.26% |
| 3 | Consumer Discretionary | 4.11% |
| 4 | Technology | 2.72% |
| 5 | Healthcare | 0.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
MongoDB
MDB
$29.5B
| $498K | 0.03% |
5,946
| – | – |
2018 Q3
1 quarter
|
|
|
LOXO
52
DELISTED
Loxo Oncology, Inc
LOXO
| $484K | 0.03% |
3,457
| – | – |
2017 Q2
6 quarters
|
|
53
Workday
WDAY
$47.4B
| $477K | 0.03% |
2,988
| – | – |
2013 Q2
22 quarters
|
|
54
DELISTED
Esperion Therapeutics
ESPR
| $450K | 0.03% |
9,773
| – | – |
2017 Q4
4 quarters
|
|
55
Range Resources
RRC
$9.68B
| $391K | 0.02% |
40,838
| – | – |
2016 Q3
9 quarters
|
|
56
DELISTED
WildHorse Resource Development
WRD
| $382K | 0.02% |
27,095
| – | – |
2018 Q2
2 quarters
|
|
57
iShares MSCI ACWI ETF
ACWI
$32.9B
| $381K | 0.02% |
5,937
+55
| +0.9% | +$3.78K |
2015 Q1
15 quarters
|
|
58
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $342K | 0.02% |
7,510
| – | – |
2015 Q4
12 quarters
|
|
59
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $331K | 0.02% |
1,095
| – | – |
2015 Q4
12 quarters
|
|
60
DHI Group
DHX
$217M
| $326K | 0.02% |
214,416
| – | – |
2015 Q4
12 quarters
|
|
61
Natera
NTRA
$58.3B
| $301K | 0.02% |
21,574
| – | – |
2016 Q2
10 quarters
|
|
|
TSRO
62
DELISTED
TESARO, Inc.
TSRO
| $299K | 0.02% |
+4,028
| New | +$194K |
2018 Q4
0 quarters
|
|
63
IQVIA
IQV
$44.6B
| $286K | 0.02% |
2,459
| – | – |
2018 Q3
1 quarter
|
|
64
DELISTED
Asensus Surgical, Inc.
ASXC
| $282K | 0.02% |
9,586
-7,574
| -44% | -$344K |
2018 Q2
2 quarters
|
|
|
CRCM
65
DELISTED
CARE.COM, INC.
CRCM
| $253K | 0.02% |
13,115
| – | – |
2017 Q4
4 quarters
|
|
66
Qualcomm
QCOM
$191B
| $250K | 0.02% |
4,400
| – | – |
2013 Q2
22 quarters
|
|
|
AIMT
67
DELISTED
Aimmune Therapeutics
AIMT
| $248K | 0.02% |
10,385
| – | – |
2017 Q4
4 quarters
|
|
|
CNST
68
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $247K | 0.02% |
+61,643
| New | +$372K |
2018 Q4
0 quarters
|
|
69
DELISTED
Redfin
RDFN
| $233K | 0.01% |
16,170
| – | – |
2018 Q2
2 quarters
|
|
70
Senseonics Holdings Inc
SENS
$435M
| $156K | 0.01% |
3,019
| – | – |
2017 Q4
4 quarters
|
|
|
IMMU
71
DELISTED
Immunomedics Inc
IMMU
| $156K | 0.01% |
10,924
| – | – |
2018 Q2
2 quarters
|
|
72
DELISTED
Aerohive Networks
HIVE
| $70K | ﹤0.01% |
21,532
+9,170
| +74% | +$34.5K |
2018 Q3
1 quarter
|
|
|
73
iShares Core US Aggregate Bond ETF
AGG
$138B
| – | – |
-84,631
| Closed | -$8.93M | – |
|
74
CRISPR Therapeutics
CRSP
$4.98B
| – | – |
-5,484
| Closed | -$243K | – |
|
|
75
DELISTED
R1 RCM Inc. Common Stock
RCM
| – | – |
-1,792,093
| Closed | -$18.2M | – |
|
Similar funds
TCIM
Jasper Ridge Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Jasper Ridge Partners held 77 positions worth $1.63B, down 11% from $1.82B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Jasper Ridge Partners's Q4 2018 filing shows 4 new, 9 increased, 8 reduced and 5 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 2,144,554 shares worth $118M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $108M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, up from 80% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Jasper Ridge Partners's largest Q4 2018 buy was iShares Core MSCI EAFE ETF: 2,144,554 shares worth $118M.
- Jasper Ridge Partners added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $33M increase.
- Jasper Ridge Partners's biggest Q4 2018 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $108M.
- Jasper Ridge Partners fully exited R1 RCM Inc. Common Stock in Q4 2018, selling an estimated $18.2M.
- Jasper Ridge Partners's ten largest holdings make up 91% of its $1.63B portfolio in Q4 2018.
- Jasper Ridge Partners opened 4 new positions and closed 5 in Q4 2018.
- Jasper Ridge Partners's portfolio value fell 11% quarter-over-quarter to $1.63B.
Based on Jasper Ridge Partners's 13F filing for Q4 2018, filed 13 Feb 2019.